Live
  • Stocks
  • ETFs
  • Commodities
    AstraZeneca's $50B U.S. Bet Amid Pharma Tariff Tensions

    AstraZeneca's $50B U.S. Bet Amid Pharma Tariff Tensions

    AstraZeneca announces a landmark $50 billion investment in the U.S., centering on a new state-of-t...

    Read More